The last couple of decades has seen increased attention by scientists and medical researchers on drug repurposing and the potential of fenbendazole. Fenbendazole has traditionally been used as an ...

A mum from Rhos-on-Sea with terminal cancer says she has been "blown away" by the response of the community after starting a fundraiser ...

Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted ...

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential to significantly boost the immune system’s ability to ...

Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others. A study published in Nature Communications, by a multidisciplinary team ...

After the leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn ...

Subscribe to the Veterinary Apothecary newsletter on LinkedIn. Federal Approvals. FDA approves first and only second-generation Janus kinase inhibitor. Atinvicitinib tablets (Nume ...

Capturing Unicorns: Targeting Cancers With TP53 Mutations, RAS Alterations Beyond G12C, and MTAP Loss—No Target Is Out of the Realm of Possibility Bispecific antibodies (bsAbs) have emerged as a novel ...

TerraPower will invest $450 million for a new South Philadelphia plant to produce radioactive molecules for cancer research.

WILMINGTON, DE — The European Commission has approved Zynyz (retifanlimab), developed by Incyte (Nasdaq: INCY), in ...